Answers are grounded in this paper and cite their sources.
Short-term treatment with oral tofacitinib results in significant clinical improvement in patients with moderate-to-severe plaque psoriasis and is generally well tolerated.
No takes yet. Share an insight, caveat, or question.
Papp et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: